These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38042056)

  • 1. Association of clinical parameters and polygenic risk scores for body mass index, schizophrenia, and diabetes with antipsychotic-induced weight gain.
    Franz M; Papiol S; Simon MS; Barton BB; Glockner C; Spellmann I; Riedel M; Heilbronner U; Zill P; Schulze TG; Musil R
    J Psychiatr Res; 2024 Jan; 169():184-190. PubMed ID: 38042056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study.
    Yoshida K; Marshe VS; Elsheikh SSM; Maciukiewicz M; Tiwari AK; Brandl EJ; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    Pharmacogenomics J; 2023 Sep; 23(5):119-126. PubMed ID: 37106021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans.
    Maciukiewicz M; Tiwari AK; Zai CC; Gorbovskaya I; Laughlin CP; Nurmi EL; Liebermann JA; Meltzer HY; Kennedy JL; Müller DJ
    Schizophr Res; 2019 Oct; 212():204-212. PubMed ID: 31447353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis.
    Yoshida K; Maciukiewicz M; Zai CC; Gonçalves VF; Brandl EJ; Lieberman JA; Meltzer HY; Tiwari AK; Kennedy JL; Müller DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109952. PubMed ID: 32335267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
    Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
    Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.
    Yu H; Wang L; Lv L; Ma C; Du B; Lu T; Jin C; Yan H; Yang Y; Li W; Ruan Y; Zhang H; Zhang H; Mi W; Mowry B; Ma W; Li K; Zhang D; Yue W
    Schizophr Bull; 2016 May; 42(3):814-23. PubMed ID: 26656879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain.
    Maciukiewicz M; Gorbovskaya I; Tiwari AK; Zai CC; Freeman N; Meltzer HY; Kennedy JL; Müller DJ
    J Neural Transm (Vienna); 2019 Jan; 126(1):27-33. PubMed ID: 30229349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The positive association between antipsychotic-induced weight gain and therapeutic response: New biotypes of schizophrenia.
    Lu Z; Zhang Y; Sun Y; Liao Y; Kang Z; Feng X; Yan H; Li J; Wang L; Lu T; Zhang D; Huang Y; Yue W
    Psychiatry Res; 2023 Jun; 324():115226. PubMed ID: 37116323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation.
    Liao Y; Yu H; Zhang Y; Lu Z; Sun Y; Guo L; Guo J; Kang Z; Feng X; Sun Y; Wang G; Su Z; Lu T; Yang Y; Li W; Lv L; Yan H; Zhang D; Yue W
    Mol Psychiatry; 2024 Jun; 29(6):1857-1868. PubMed ID: 38336841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.
    Brandl EJ; Frydrychowicz C; Tiwari AK; Lett TA; Kitzrow W; Büttner S; Ehrlich S; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ; Puls I
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):134-41. PubMed ID: 22426215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of SNAP25 variants with schizophrenia and antipsychotic-induced weight change in large-scale schizophrenia patients.
    Guan F; Zhang T; Han W; Zhu L; Ni T; Lin H; Liu D; Chen G; Xiao J; Li T
    Schizophr Res; 2020 Jan; 215():250-255. PubMed ID: 31653583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort).
    Ter Hark SE; Jamain S; Schijven D; Lin BD; Bakker MK; Boland-Auge A; Deleuze JF; Troudet R; Malhotra AK; Gülöksüz S; Vinkers CH; Ebdrup BH; Kahn RS; Leboyer M; Luykx JJ
    J Psychopharmacol; 2020 May; 34(5):524-531. PubMed ID: 32126890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.
    Zhang JP; Robinson D; Yu J; Gallego J; Fleischhacker WW; Kahn RS; Crespo-Facorro B; Vazquez-Bourgon J; Kane JM; Malhotra AK; Lencz T
    Am J Psychiatry; 2019 Jan; 176(1):21-28. PubMed ID: 30392411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain.
    Brandl EJ; Tiwari AK; Lett TA; Shaikh SA; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    Hum Psychopharmacol; 2013 Mar; 28(2):183-7. PubMed ID: 23364847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.
    Ujike H; Nomura A; Morita Y; Morio A; Okahisa Y; Kotaka T; Kodama M; Ishihara T; Kuroda S
    J Clin Psychiatry; 2008 Sep; 69(9):1416-22. PubMed ID: 19193342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathway analysis associates alterations in obesity-related genes and antipsychotic-induced weight gain.
    Corfitsen HT; Krantz B; Larsen A; Drago A
    Acta Neuropsychiatr; 2020 Apr; 32(2):72-83. PubMed ID: 31619305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in gene expression related to antipsychotic induced weight gain.
    Sainz J; Prieto C; Crespo-Facorro B
    PLoS One; 2019; 14(4):e0215477. PubMed ID: 30986260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.
    Brandl EJ; Tiwari AK; Zai CC; Nurmi EL; Chowdhury NI; Arenovich T; Sanches M; Goncalves VF; Shen JJ; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    Pharmacogenomics J; 2016 Aug; 16(4):352-6. PubMed ID: 26323598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis.
    Muntané G; Vázquez-Bourgon J; Sada E; Martorell L; Papiol S; Bosch E; Navarro A; Crespo-Facorro B; Vilella E
    Eur Psychiatry; 2023 Feb; 66(1):e28. PubMed ID: 36852609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.